Study links recurring binge drinking with advanced fibrosis
Women who report binge drinking at least once a month had increased odds of advanced liver fibrosis in a large U.S. analysis, according to a study published in Alcohol: Clinical and Experimental Research. The association remained significant for women after researchers accounted for average daily alcohol consumption, a result the study says may point to a stronger independent effect of binge-drinking frequency in women.
Advanced fibrosis is a serious stage of liver scarring and an important predictor of outcomes and mortality in steatotic liver disease. That umbrella term, formerly associated with the label fatty liver disease, covers liver conditions connected with alcohol use, metabolic dysfunction, or both.
The findings do not establish that a single pattern of drinking causes fibrosis in an individual person. But they add detail to a question that matters for clinical screening and public-health messaging: whether the frequency of heavy episodic drinking carries information beyond a person’s average alcohol intake.
What the researchers measured
The investigators used National Health and Nutrition Examination Survey data spanning two decades through 2020. The analysis included 43,447 nationally representative U.S. adults.
For this study, binge drinking meant consuming four or more drinks on one occasion for women and five or more for men. Participants were grouped by reported frequency: no binge drinking, less than monthly binge drinking, more than monthly but less than weekly binge drinking, and at least weekly binge drinking.
- Seventy-two percent of participants reported no binge drinking.
- Fourteen percent reported binge drinking less than once a month.
- Six percent reported it more than monthly but less than weekly.
- Eight percent reported binge drinking at least weekly.
Across those groups, the odds of advanced fibrosis rose as reported binge-drinking frequency increased. The association persisted after adjustments for demographics, other illnesses, and additional factors described by the researchers.
A difference between women and men
The study’s central finding was not simply that heavier episodic drinking tracked with fibrosis. The pattern differed by sex once average daily alcohol consumption was considered.
Among men, the reported link between binge drinking and advanced fibrosis no longer appeared after that adjustment. The authors said this result suggests cumulative alcohol exposure may be more relevant than binge drinking itself for men in this dataset.
Among women, however, binge-drinking frequency remained significant after average daily alcohol consumption was taken into account. The association was especially notable among women reporting binge drinking at least monthly. The study describes more-than-monthly binge drinking among women as presenting odds of advanced fibrosis similar to the alcohol-use level implicated in metabolic dysfunction and alcohol-associated steatotic liver disease.
That distinction is important because average daily intake can obscure how alcohol is consumed. Two people may report similar average consumption over time while having very different drinking patterns. The analysis suggests that, for women in particular, recurring occasions involving four or more drinks may be relevant when assessing liver risk.
Why the result matters
Steatotic liver disease includes conditions with overlapping metabolic and alcohol-related contributors. Researchers and clinicians therefore need ways to describe alcohol exposure that are useful without treating it as a single, simple measure.
The study notes that earlier research had linked heavy episodic drinking to certain liver conditions and to liver-related death, while its role in steatotic liver disease had remained undefined. By focusing on advanced fibrosis, the analysis addresses a marker associated with worse liver outcomes.
The results may also sharpen discussions about thresholds. Rather than limiting attention to daily or weekly averages, clinicians examining liver health may need to ask about the frequency of high-intensity drinking occasions. The source material describes the study as the first to identify a threshold in which more-than-monthly binge drinking among women was associated with odds of advanced fibrosis comparable to a level of alcohol use relevant to metabolic dysfunction and alcohol-associated disease.
What the study does and does not say
The analysis is based on a large, nationally representative sample and examines alcohol patterns over a long span of survey data. It also adjusted for demographic characteristics, illnesses, and other factors, strengthening the reported association.
Still, the result should be read as an association in survey data, not as a personal diagnosis or a precise prediction of an individual’s risk. The source describes reported binge-drinking frequency and reports odds of advanced fibrosis; it does not say that every person who meets the binge-drinking definition will develop liver scarring, or that people who do not binge drink face no risk.
For readers, the practical takeaway is that pattern appears to matter alongside total consumption. The study’s sex-specific findings add evidence that recurring binge drinking deserves particular attention in assessments of liver health among women.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com
